207 related articles for article (PubMed ID: 15273083)
1. Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
Gogos CA; Skoutelis A; Lekkou A; Drosou E; Starakis I; Marangos MN; Bassaris HP
Antimicrob Agents Chemother; 2004 Aug; 48(8):2793-8. PubMed ID: 15273083
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
Simpson AJ; Smith MD; Weverling GJ; Suputtamongkol Y; Angus BJ; Chaowagul W; White NJ; van Deventer SJ; Prins JM
J Infect Dis; 2000 Feb; 181(2):621-5. PubMed ID: 10669346
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia.
Leonidou L; Mouzaki A; Michalaki M; DeLastic AL; Kyriazopoulou V; Bassaris HP; Gogos CA
J Infect; 2007 Oct; 55(4):340-6. PubMed ID: 17631968
[TBL] [Abstract][Full Text] [Related]
5. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
Gogos CA; Drosou E; Bassaris HP; Skoutelis A
J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
[TBL] [Abstract][Full Text] [Related]
7. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz C; Carlet J; Fitting C; Misset B; Blériot JP; Cavaillon JM
J Clin Invest; 1991 Nov; 88(5):1747-54. PubMed ID: 1939659
[TBL] [Abstract][Full Text] [Related]
9. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
Groeneveld PH; Kwappenberg KM; Langermans JA; Nibbering PH; Curtis L
Cytokine; 1997 Feb; 9(2):138-42. PubMed ID: 9071565
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Noel GJ; Bush K; Bagchi P; Ianus J; Strauss RS
Clin Infect Dis; 2008 Mar; 46(5):647-55. PubMed ID: 18225981
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with gram-negative urosepsis. Urosepsis Study Group.
Luchi M; Morrison DC; Opal S; Yoneda K; Slotman G; Chambers H; Wiesenfeld H; Lemke J; Ryan JL; Horn D
J Endotoxin Res; 2000; 6(1):25-31. PubMed ID: 11061029
[TBL] [Abstract][Full Text] [Related]
13. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
Mészáros J; Tołłoczko T; Stachlewska E; Tyc Z; Jeljaszewicz J
J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
[TBL] [Abstract][Full Text] [Related]
15. Effect of antimicrobial agents on the toll-like receptors and inflammatory cytokines in liver tissue of the alcohol-induced liver disease in rats with Vibrio vulnificus sepsis.
Lu ZQ; Li MF; Qiu QM; Liang H; Zhou TL; Hong GL; Wu B
Chin Med J (Engl); 2009 Aug; 122(16):1910-6. PubMed ID: 19781370
[TBL] [Abstract][Full Text] [Related]
16. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H
Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Maskin B; Fontán PA; Spinedi EG; Gammella D; Badolati A
Crit Care Med; 2002 Feb; 30(2):349-54. PubMed ID: 11889308
[TBL] [Abstract][Full Text] [Related]
18. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
19. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock.
Brunialti MK; Martins PS; Barbosa de Carvalho H; Machado FR; Barbosa LM; Salomao R
Shock; 2006 Apr; 25(4):351-7. PubMed ID: 16670636
[TBL] [Abstract][Full Text] [Related]
20. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
